Abstract：Objective: To investigate the effects of loratadine and montelukast on serum levels of ICAM-1, ECP, EOS and CSF in patients with allergic rhinitis. Methods: 104 cases of allergic rhinitis patients were from August 2013 to October to 2015 period in our hospital clinical cases, by drawing lots were randomly divided into the control group and the experimental group, 52 cases in each group. The control group received oral loratadine treatment, and the experimental group was treated with montelukast on the basis of the control group. The clinical efficacy, the levels of serum ICAM-1, ECP, EOS, CSF, nasal symptoms, VAS score and adverse reactions before and after treatment were compared between the two groups. Results: After treatment, the clinical efficacy of the experimental group (90.38%) was higher than that of the control group (80.77%), and the difference was statistically significant (P<0.05). There was no significant difference in serum ICAM-1, ECP, EOS and CSF levels between the two groups before treatment (P<0.05). After treatment, the VAS scores of the experimental group were significantly lower than those of the control group [(6.69 +2.08) VS (7.86 +2.69), (374.58 +69.83) VS (468.46 +80.53), (3.02 +0.88) VS (3.91 +0.89), (16.69 +3.47) VS (29.58 +5.73)]. After treatment, the nasal symptoms of the two groups were significantly lower than those of the control group. The adverse reactions in the experimental group were significantly lower than those in the control group, and there was no difference between the two groups (P>0.05). Conclusion: Loratadine combined with montelukast sodium has a definite therapeutic effect on allergic rhinitis. It can reduce the levels of serum ICAM-1, ECP, EOS and CSF, improve clinical symptoms, and is worthy of clinical application.
刘怡君, 曾邦兵, 曾浪. 氯雷他定联合孟鲁司特钠对变应性鼻炎患者血清ICAM-1 ECP EOS CSF的影响研究[J]. 河北医学, 2019, 25(2): 280-283.
LIU Yijun, ZENG Bangbing, ZENG Lang. Effect of Loratadine combined with Montelukast Sodium on Serum ICAM-1 ECP EOS and CSF in Patients with Allergic Rhinitis. HeBei Med, 2019, 25(2): 280-283.
2019, Vol. 25 
冀公网安备13080202000677号